FPB
UTHR icon

First PREMIER Bank’s United Therapeutics UTHR Stock Holding History

First PREMIER Bank’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100
Closed -$22K – 373
2023
Q2 		$22K Hold
100
– – 0.01% 283
2023
Q1 		$22K Hold
100
– – 0.01% 306
2022
Q4 		$28K Hold
100
– – 0.01% 269
2022
Q3 		$21K Buy
+100
New +$22.4K 0.01% 294

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

First PREMIER Bank's UTHR Position: Q3 2023 in Review

First PREMIER Bank sold out of United Therapeutics (UTHR) in Q3 2023, closing a stake of 100 shares — an estimated $22K sold.

First PREMIER Bank first reported a position in UTHR in Q3 2022 and held it in 4 quarters. The position peaked at $28K in Q4 2022. 508 funds tracked by Wall St. Rank hold UTHR as of Q3 2023.

  • First PREMIER Bank reported no remaining United Therapeutics position as of Q3 2023 after selling out during the quarter.
  • First PREMIER Bank sold 100 United Therapeutics shares in Q3 2023, an estimated $22K.
  • First PREMIER Bank first reported a position in United Therapeutics in Q3 2022 and held it in 4 quarters.
  • First PREMIER Bank's United Therapeutics position peaked at $28K in Q4 2022.
  • 508 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2023.

Based on First PREMIER Bank's 13F filing for Q3 2023, filed 16 Oct 2023.